A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With Achondroplasia
Clinical trial NCT04085523 · COMPLETED
Trial details
- NCT number
- NCT04085523
- Sponsor
- Ascendis Pharma A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-24
- Primary completion
- 2022-09-27
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.